PharmaCyte Biotech Inc (PMCB) — Cash Flow-to-Debt Ratio
PharmaCyte Biotech Inc (PMCB) has a Cash Flow-to-Debt Ratio of -0.12x as of April 2026, meaning its operating cash flow of $-1.39 Million could theoretically repay 0% of its total liabilities ($11.77 Million) in one year. See PMCB financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
PharmaCyte Biotech Inc Cash Flow-to-Debt Ratio (2002–2026)
Historical debt coverage capacity for PharmaCyte Biotech Inc across 25 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of PharmaCyte Biotech Inc.
Annual Cash Flow-to-Debt Ratio for PharmaCyte Biotech Inc (2002–2026)
Year-by-year debt coverage analysis for PharmaCyte Biotech Inc. Check how high is PharmaCyte Biotech Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.44x | $-5.15 Million | $11.77 Million | ▲ +51.8% |
| 2025 | -0.91x | $-2.98 Million | $3.28 Million | ▼ -761.2% |
| 2024 | -0.11x | $-2.15 Million | $20.39 Million | ▲ +98.4% |
| 2023 | -6.47x | $-3.79 Million | $586.58K | ▼ -10.6% |
| 2022 | -5.85x | $-4.12 Million | $704.37K | ▼ -27.2% |
| 2021 | -4.60x | $-3.33 Million | $724.78K | ▼ -111.8% |
| 2020 | -2.17x | $-2.34 Million | $1.08 Million | ▲ +44.0% |
| 2019 | -3.87x | $-2.88 Million | $742.85K | ▲ +50.9% |
| 2018 | -7.89x | $-5.08 Million | $644.17K | ▼ -37.0% |
| 2017 | -5.76x | $-3.34 Million | $580.25K | ▲ +15.6% |
| 2016 | -6.82x | $-4.35 Million | $637.64K | ▼ -200.8% |
| 2015 | -2.27x | $-4.56 Million | $2.01 Million | ▲ +45.8% |
| 2014 | -4.18x | $-1.56 Million | $373.67K | ▼ -3968.3% |
| 2013 | -0.10x | $-390.43K | $3.80 Million | ▼ -50.1% |
| 2012 | -0.07x | $-259.29K | $3.79 Million | ▼ -20.7% |
| 2011 | -0.06x | $-225.23K | $3.97 Million | ▲ +81.6% |
| 2010 | -0.31x | $-974.06K | $3.15 Million | ▲ +24.0% |
| 2009 | -0.41x | $-1.19 Million | $2.92 Million | ▲ +93.8% |
| 2008 | -6.60x | $-1.19 Million | $180.56K | ▼ -122.9% |
| 2007 | -2.96x | $-351.60K | $118.81K | ▼ -99.8% |
| 2006 | -1.48x | $-1.07 Million | $723.89K | ▲ +13.6% |
| 2005 | -1.71x | $-2.80 Million | $1.63 Million | ▼ -155.4% |
| 2004 | -0.67x | $-221.03K | $329.13K | ▲ +95.5% |
| 2003 | -14.84x | $-37.46K | $2.52K | ▼ -429.9% |
| 2002 | -2.80x | $-21.99K | $7.86K | — |